Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control studySalim Yusuf, Sonia S. Anand, Stephanie Ôunpuu et al.|The Lancet|2005Cited by 2.9k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial FibrillationJohn W. Eikelboom, Salim Yusuf, Hans‐Christoph Diener et al.|Circulation|2011Cited by 1.1k
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trialLars Wallentin, Stuart J. Connolly, Salim Yusuf et al.|The Lancet|2010Cited by 1k
Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic RangeStuart J. Connolly, Salim Yusuf, Janice Pogue et al.|Circulation|2008Cited by 873
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trialsJane Armitage, Martin Landray, Colin Baigent et al.|The Lancet|2019Cited by 785